The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

32 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.EBI
University of Athens
Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.EBI
University of Athens
Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity.EBI
University of Athens
Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.EBI
University of Athens
Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo.EBI
University of Athens
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.EBI
University of Athens
One-step semisynthesis of oleacein and the determination as a 5-lipoxygenase inhibitor.EBI
University of Athens
New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.EBI
University of Athens
Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases.EBI
University of Athens
Design, synthesis and melatoninergic activity of new unsubstituted and beta,beta'-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides.EBI
University of Athens
Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.EBI
University of Athens
Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.EBI
University of Athens
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.EBI
University of Athens
Design of more potent squalene synthase inhibitors with multiple activities.EBI
University of Athens
Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.EBI
University of Athens
Isoflavonoids from Erythrina poeppigiana: evaluation of their binding affinity for the estrogen receptor.EBI
University of Athens
A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.EBI
University of Athens
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.EBI
University of Athens
Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.EBI
University of Athens
Three new arylobenzofurans from Onobrychis ebenoides and evaluation of their binding affinity for the estrogen receptor.EBI
University of Athens
An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.EBI
University of Athens
Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents.EBI
University of Athens
Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.EBI
University of Athens
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.EBI
University of Athens
Optimizing the Pharmacological Profile of New Bifunctional Antihyperlipidemic/Antioxidant Morpholine Derivatives.EBI
University of Athens
Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase.EBI
University of Athens
Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors.EBI
University of Athens
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.EBI
University of Athens
Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.EBI
University of Athens
Method of treatment using substituted imidazo[1,2b]pyridazine compoundsBDB
Array Biopharma
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsBDB
Array Biopharma
Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin.BDB
University of Groningen